(VIANEWS) – TOUR EIFFEL (EIFF.PA), ELMERA GROUP (ELMRA.OL), VAN DE VELDE (VAN.BR) are the highest payout ratio stocks on this list.
We have congregated information concerning stocks with the highest payout ratio so far. The payout ratio in itself isn’t a guarantee of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. TOUR EIFFEL (EIFF.PA)
625% Payout Ratio
Société de la Tour Eiffel is an integrated property company with €1.8bn in assets and a powerful service culture. An agile operator, it works across multiple asset classes (offices, logistics, managed residential, retail) located in Greater Paris and the major regional metropolises. It is active throughout the real estate cycle, supporting its tenants, companies of all sizes and sectors, via a rigorous direct management process. Société de la Tour Eiffel takes a pro- active cross-disciplinary approach to CSR that is fully integrated with its business strategy.
Earnings Per Share
As for profitability, TOUR EIFFEL has a trailing twelve months EPS of €0.24.
PE Ratio
TOUR EIFFEL has a trailing twelve months price to earnings ratio of 60.21. Meaning, the purchaser of the share is investing €60.21 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.54%.
Volume
Today’s last reported volume for TOUR EIFFEL is 176 which is 92.23% below its average volume of 2266.
Revenue Growth
Year-on-year quarterly revenue growth declined by 57%, now sitting on 84.5M for the twelve trailing months.
Moving Average
TOUR EIFFEL’s value is way below its 50-day moving average of €16.70 and way under its 200-day moving average of €19.19.
Yearly Top and Bottom Value
TOUR EIFFEL’s stock is valued at €14.45 at 12:10 EST, below its 52-week low of €14.95.
More news about TOUR EIFFEL.
2. ELMERA GROUP (ELMRA.OL)
432.1% Payout Ratio
Elmera Group ASA, together with its subsidiaries, engages in the purchase, sale, and portfolio management of electrical power to households, private and public companies, and municipalities in Norway. It operates through Consumer, Business, and Nordic segments. The Consumer segment sells electrical power and related services to private consumers. The Business segment sells electrical power and related services to business consumers. The Nordic segment sells electrical power and related services to consumers in Finland and Sweden. The company also manages, researches, and develops products and services related to electrical power; and offers payment solutions. In addition, it provides mobile phone services to private customers. The company was formerly known as Fjordkraft Holding ASA and changed its name to Elmera Group ASA in April 2022. Elmera Group ASA was founded in 2001 and is headquartered in Bergen, Norway.
Earnings Per Share
As for profitability, ELMERA GROUP has a trailing twelve months EPS of kr0.84.
PE Ratio
ELMERA GROUP has a trailing twelve months price to earnings ratio of 24.6. Meaning, the purchaser of the share is investing kr24.6 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.02%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 19.9%, now sitting on 26.86B for the twelve trailing months.
Moving Average
ELMERA GROUP’s worth is under its 50-day moving average of kr21.84 and way above its 200-day moving average of kr18.47.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Apr 27, 2023, the estimated forward annual dividend rate is 1.5 and the estimated forward annual dividend yield is 7.23%.
More news about ELMERA GROUP.
3. VAN DE VELDE (VAN.BR)
72.41% Payout Ratio
Van de Velde NV, together with its subsidiaries, designs, develops, manufactures, and markets fashionable luxury lingerie and swimwear for women worldwide. It operates through two segments, business to business (B2B) and direct to consumer (D2C). The company offers its products under the PrimaDonna, Marie Jo, Andres Sarda, and Lingerie Styling brands. It also operates retail websites; stores; and boutiques and department stores. The company was founded in 1919 and is headquartered in Schellebelle, Belgium. Van de Velde NV is a subsidiary of Van de Velde Holding NV.
Earnings Per Share
As for profitability, VAN DE VELDE has a trailing twelve months EPS of €2.86.
PE Ratio
VAN DE VELDE has a trailing twelve months price to earnings ratio of 11.73. Meaning, the purchaser of the share is investing €11.73 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.23%.
Sales Growth
VAN DE VELDE’s sales growth for the current quarter is 5.3%.
Moving Average
VAN DE VELDE’s value is higher than its 50-day moving average of €33.22 and higher than its 200-day moving average of €32.92.
More news about VAN DE VELDE.
4. HØLAND OG SETSKOG (HSPG.OL)
68.83% Payout Ratio
Høland og Setskog Sparebank provides banking services for the retail and corporate markets in Norway. It offers deposits and loans, as well as insurance products. The company was formerly known as Holand Sparebank and changed its name to Høland og Setskog Sparebank in 2010. The company was founded in 1849 and is headquartered in Bjørkelangen, Norway.
Earnings Per Share
As for profitability, HØLAND OG SETSKOG has a trailing twelve months EPS of kr9.59.
PE Ratio
HØLAND OG SETSKOG has a trailing twelve months price to earnings ratio of 14.18. Meaning, the purchaser of the share is investing kr14.18 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.82%.
Yearly Top and Bottom Value
HØLAND OG SETSKOG’s stock is valued at kr136.00 at 12:10 EST, way under its 52-week high of kr169.00 and higher than its 52-week low of kr131.00.
Moving Average
HØLAND OG SETSKOG’s value is below its 50-day moving average of kr148.52 and under its 200-day moving average of kr146.36.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Mar 11, 2022, the estimated forward annual dividend rate is 7 and the estimated forward annual dividend yield is 4.55%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 13.2%, now sitting on 147.48M for the twelve trailing months.
More news about HØLAND OG SETSKOG.
5. UCB (UCB.BR)
60.47% Payout Ratio
UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. It also offers Evenity for the treatment of osteoporosis in postmenopausal women; BIMZELX for treating psoriasis, psoriatic arthritis, axial spondyloarthritis, and hidradenitis suppurativa; and dapirolizumab pegol for systemic lupus erythematosus. In addition, the company is involved in developing rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; zilucoplan to treat myasthenia gravis and immune-mediated necrotizing myopathy; staccato alprazolam to treat tereotypical prolonged seizure; Bepranemab to treat Alzheimer's disease; and UCB0599 to treat Parkinson's disease. Further, it engages in contract manufacturing activities. UCB SA has collaboration agreements with Amgen, Biogen, Roche/Genentech, Novartis, Otsuka, and doc.ai. It operates in the United States, Japan, Germany, rest of Europe, Spain, France, China, Italy, the United Kingdom, Ireland, Belgium, and internationally. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.
Earnings Per Share
As for profitability, UCB has a trailing twelve months EPS of €2.15.
PE Ratio
UCB has a trailing twelve months price to earnings ratio of 37.9. Meaning, the purchaser of the share is investing €37.9 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.81%.
More news about UCB.
6. Coca-ColaEuropacif (CCEP.AS)
51.06% Payout Ratio
Coca-Cola Europacific Partners PLC, together with its subsidiaries, produces, distributes, and sells a range of non-alcoholic ready to drink beverages. It offers flavours, mixers, and energy drinks; soft drinks, waters, enhanced water, and isotonic drinks; and ready-to-drink tea and coffee, juices, and other drinks. The company provides its products under the Coca-Cola, Diet Coke, Coca-Cola Zero Sugar, Fanta, Sprite, Monster Energy, Coca-Cola Energy, Relentless, nalu, URGE, BURN, Kuli, REIGN, POWERADE, Appletiser, Schweppes, FINLEY, mezzo mix, Royal Bliss, Lift, Vio SCHORLE, Coca-Cola Signature Mixers, NORDIC MIST, smartwater, Chaudfontaine, AQUARIUS, VILAS del Turbon, BONAQUA, Apollinaris, Krystal, Honest, Costa Coffee, Fuzetea, CHAQWA, NESTEA, Capri-Sun, Oasis, Minute Maid, MER, and Tropico brands. In addition, it engages in the bottling and other operations. The company was formerly known as Coca-Cola European Partners plc and changed its name to Coca-Cola Europacific Partners PLC in May 2021. Coca-Cola Europacific Partners PLC was founded in 1904 and is based in Uxbridge, the United Kingdom.
Earnings Per Share
As for profitability, Coca-ColaEuropacif has a trailing twelve months EPS of €3.29.
PE Ratio
Coca-ColaEuropacif has a trailing twelve months price to earnings ratio of 17.66. Meaning, the purchaser of the share is investing €17.66 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.75%.
Yearly Top and Bottom Value
Coca-ColaEuropacif’s stock is valued at €58.10 at 12:10 EST, below its 52-week high of €61.60 and way higher than its 52-week low of €42.94.
Revenue Growth
Year-on-year quarterly revenue growth grew by 15.2%, now sitting on 17.32B for the twelve trailing months.
Volume
Today’s last reported volume for Coca-ColaEuropacif is 65 which is 99.74% below its average volume of 25766.
Moving Average
Coca-ColaEuropacif’s worth is under its 50-day moving average of €58.96 and higher than its 200-day moving average of €54.01.
More news about Coca-ColaEuropacif.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of €1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
More news about 1.
